Health care startups in the United Kingdom
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Fresha | London | Series C | $80.0M | 2026-05-21 |
| bit.bio | Cambridge | Series D | $25.0M | 2026-11-04 |
| T-Therapeutics | Cambridge | Series B | $133.0M | 2026-11-05 |
| Basecamp Research | London | Series C | $140.0M | 2026-09-23 |
| Brainomix | Oxford | Series C | $6.5M | 2026-02-24 |
| Leo Cancer Care | Harley | Series D | $65.0M | 2026-07-08 |
| Microbiotica | Cambridge | Series C | $47.9M | 2026-10-16 |
| Adsilico | Leeds | Series A | $13.3M | 2026-10-26 |
8 rows of the CSV in 5 of its 18 columns.
- The 1,388 health care startups in the United Kingdom have raised $14.0B in total.
- 170 of them closed their most recent round in the last 12 months, $2.8B combined.
- The largest of those rounds is OMass Therapeutics' $310.0M Series C, dated October 2026.
- The most recent is T-Therapeutics' $133.0M Series B on 5 November 2026.
- Innovate UK is an investor in 44 of them, more than any other fund.
- Biotech is the most common other sector, with 457 companies (33%).
- 39% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 1 to 10 employees (51% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 1,388| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge | Series B | $133.0M | 2026-11-05 | $224.6M | F-Prime, Sofinnova Partners, Digitalis Ventures +2 | 51 to 100 | 2022 |
| bit.bio | Bit.bio provides engineered human cell products and platform services for biomedical research and drug discovery. | Biotech | Cambridge | Series D | $25.0M | 2026-11-04 | $250.0M | Metaplanet, Foresite Capital | 101 to 250 | 2016 |
| OSSTEC | OSSTEC develops products for orthopaedic treatment. | Hardware | London | Series A | $8.0M | 2026-11-03 | $12.7M | SFC Capital, Parkwalk Advisors, Embryo Ventures +1 | 11 to 50 | 2021 |
| Bioliberty | Bioliberty develops rehabilitation solutions for degenerative and traumatic conditions as a medtech start-up. | Biotech | Edinburgh | Series A | $3.3M | 2026-11-02 | $17.4M | Innovate UK, Scottish Enterprise, Old College Capital +2 | 11 to 50 | 2020 |
| Adsilico | Adsilico develops new approaches to medical device innovation. | Health care | Leeds | Series A | $13.3M | 2026-10-26 | $17.8M | Parkwalk Advisors, Northern Gritstone | 1 to 10 | 2022 |
| Microbiotica | Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. | Biotech | Cambridge | Series C | $47.9M | 2026-10-16 | $130.7M | Seventure Partners, IP Group, Cambridge Innovation Capital +1 | 11 to 50 | 2016 |
| Sava Technology | Sava Technology creates under-skin sensors that continuously monitor glucose, lactate, and ketones. | Biotech | London | Series B | $36.0M | 2026-10-09 | $62.8M | SOSV, Balderton Capital, Social Starts +1 | 101 to 250 | 2016 |
| Dyad | Dyad builds trust in data and develops AI-powered tools for healthcare operations. | Artificial intelligence | London | Series A | $10.0M | 2026-09-29 | $14.0M | Plug and Play, Pantera Capital, Carbide Ventures | 11 to 50 | 2020 |
| Directed Systems | Directed Systems builds medical software and applies data science to healthcare. | Hardware | Cambridge | Seed | $25K | 2026-09-27 | $25K | Innovate UK | 11 to 50 | 2014 |
| Living Optics | Living Optics develops imaging technology. | Artificial intelligence | Milton Keynes | Series A | $20.0M | 2026-09-24 | $49.3M | Octopus Ventures, Oxford Science Enterprises, Outsized Ventures +2 | 11 to 50 | 2020 |
| Basecamp Research | Basecamp Research is a biotechnology company that uses AI and biological data to develop therapeutics. | Artificial intelligence | London | Series C | $140.0M | 2026-09-23 | $219.9M | True Ventures, redalpine, Hummingbird Ventures +1 | 51 to 100 | 2019 |
| Mironid | Mironid discovers drugs to treat degenerative kidney diseases, chronic inflammatory diseases, and cancer. | Biotech | Glasgow | Series B | $45.9M | 2026-08-05 | $90.6M | Scottish Enterprise, Sofinnova Partners, European Investment Fund +1 | 11 to 50 | 2014 |
| Qureight | Qureight develops imaging technologies and analytics software for biopharmaceutical companies. | Artificial intelligence | Cambridge | Series B | $20.0M | 2026-07-29 | $31.2M | Ascension, Playfair Capital, XTX Ventures | 11 to 50 | 2018 |
| Alchemab Therapeutics | Alchemab Therapeutics develops protective antibodies to prevent hard-to-treat diseases. | Biotech | London | Series A | $33.6M | 2026-07-09 | $151.1M | DCVC, RA Capital Management, DHVC +2 | 51 to 100 | 2019 |
| Leo Cancer Care | Leo Cancer Care develops radiation therapy technologies that treat cancer in upright patient positions. | Health care | Harley | Series D | $65.0M | 2026-07-08 | $130.3M | Alumni Ventures, EDBI, Serra Ventures +1 | 11 to 50 | 2016 |
| Neuronostics | Neuronostics develops clinical decision support systems and at-home monitoring tools for neurological conditions. | Health care | Bristol | Seed | $4.0M | 2026-06-30 | $10.2M | Innovate UK, The FSE Group, Cornwall & Isles of Scilly Investment Fund +1 | 11 to 50 | 2018 |
| Saltroad | Saltroad provides speech and language therapy services for children with speech difficulties. | Health care | Belfast | Seed | $2.0M | 2026-06-30 | $2.7M | Ascension, Techstart Ventures | 1 to 10 | 2024 |
| Hexis | Hexis uses predictive nutrition data to help athletes and nutritionists improve performance. | Artificial intelligence | London | Seed | $2.1M | 2026-06-16 | $4.7M | Baltic Ventures, APEX Capital, Sport Republic | 1 to 10 | 2018 |
| Semble | Semble develops practice management and health record software for private healthcare providers. | Health care | London | Series C | $40.3M | 2026-06-04 | $67.2M | Octopus Ventures, Salica, Triple Point Ventures +2 | 101 to 250 | 2017 |
| Apoha | Apoha is a start-up that has not yet publicly launched. | Biotech | London | Series A | $36.0M | 2026-06-03 | $36.0M | Plug and Play, Innovate UK, Intel Ignite +2 | 1 to 10 | 2021 |
| Fresha | Fresha is a marketplace platform that helps users find nearby beauty, wellness, and self-care services. | Commerce | London | Series C | $80.0M | 2026-05-21 | $299.0M | FJ Labs, Partech, Target Global +2 | 251 to 500 | 2015 |
| CellCentric | CellCentric develops small molecule therapies for treating cancer and multiple myeloma. | Biotech | Cambridge | Series D | $220.0M | 2026-05-06 | $475.7M | Innovate UK, 5Y Capital, RA Capital Management +2 | 11 to 50 | 2003 |
| Fermtech | Fermtech provides equipment that helps precision fermentation companies scale production processes. | Biotech | Oxford | Seed | $3.3M | 2026-04-07 | $3.9M | Carbon13 | 1 to 10 | 2022 |
| Corryn Biotechnologies | Corryn Biotechnologies develops wound dressing devices for chronic and complex wounds. | Biotech | Morriston | Seed | $662K | 2026-04-01 | $1.6M | SFC Capital, Innovate UK | 1 to 10 | 2021 |
| EarSwitch | EarSwitch develops in-ear biometric switches and sensors that let users control their surroundings. | Health care | Bristol | Seed | $1.5M | 2026-03-31 | $1.5M | Praetura Ventures, Newable Private Investing, UK Research and Innovation +2 | 11 to 50 | 2019 |
| Lucida Medical | Lucida Medical develops software for cancer diagnosis using MRI and radiology imaging, particularly for prostate cancer. | Biotech | Cambridge | Series A | $11.5M | 2026-03-30 | $22.5M | Innovate UK, XTX Ventures, WDH Investments | 11 to 50 | 2019 |
| Brainomix | Brainomix creates AI-powered imaging biomarkers that support precision medicine treatment decisions. | Artificial intelligence | Oxford | Series C | $6.5M | 2026-02-24 | $60.2M | Innovate UK, Parkwalk Advisors, Boehringer Ingelheim Venture Fund +1 | 51 to 100 | 2010 |
| Neupulse | Neupulse provides healthcare services. | Health care | Nottingham | Seed | $4.1M | 2026-02-12 | $7.9M | Eos, Midlands Engine Investment Fund | 11 to 50 | 2021 |
| Early Health | Early Health makes consumer bathroom hardware that detects early signs of illness. | Biotech | London | Seed | $4.7M | 2026-02-10 | $4.7M | LocalGlobe, SoftBank Vision Fund, Atomico +1 | 1 to 10 | 2022 |
| Eolas Medical | Eolas Medical organizes medical information worldwide to make healthcare simpler, safer, and smarter. | Health care | Belfast | Series A | $12.1M | 2026-01-20 | $12.1M | Ascension, 7percent Ventures | 11 to 50 | 2019 |
Table 1. Health care startups in the United Kingdom: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 1,388.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CellCentric | CellCentric develops small molecule therapies for treating cancer and multiple myeloma. | Biotech | Cambridge | Series D | $220.0M | 2026-05-06 | $475.7M | Innovate UK, 5Y Capital, RA Capital Management +2 | 11 to 50 | 2003 |
| 2 | Basecamp Research | Basecamp Research is a biotechnology company that uses AI and biological data to develop therapeutics. | Artificial intelligence | London | Series C | $140.0M | 2026-09-23 | $219.9M | True Ventures, redalpine, Hummingbird Ventures +1 | 51 to 100 | 2019 |
| 3 | T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge | Series B | $133.0M | 2026-11-05 | $224.6M | F-Prime, Sofinnova Partners, Digitalis Ventures +2 | 51 to 100 | 2022 |
| 4 | Fresha | Fresha is a marketplace platform that helps users find nearby beauty, wellness, and self-care services. | Commerce | London | Series C | $80.0M | 2026-05-21 | $299.0M | FJ Labs, Partech, Target Global +2 | 251 to 500 | 2015 |
| 5 | Leo Cancer Care | Leo Cancer Care develops radiation therapy technologies that treat cancer in upright patient positions. | Health care | Harley | Series D | $65.0M | 2026-07-08 | $130.3M | Alumni Ventures, EDBI, Serra Ventures +1 | 11 to 50 | 2016 |
| 6 | KatKin | KatKin produces healthy cat food that supports digestion, shiny coats, and energy. | Commerce | London | Series C | $50.0M | 2025-12-13 | $79.0M | Octopus Ventures, Redbus Ventures, Verlinvest +2 | 101 to 250 | 2019 |
| 7 | Microbiotica | Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. | Biotech | Cambridge | Series C | $47.9M | 2026-10-16 | $130.7M | Seventure Partners, IP Group, Cambridge Innovation Capital +1 | 11 to 50 | 2016 |
| 8 | Mironid | Mironid discovers drugs to treat degenerative kidney diseases, chronic inflammatory diseases, and cancer. | Biotech | Glasgow | Series B | $45.9M | 2026-08-05 | $90.6M | Scottish Enterprise, Sofinnova Partners, European Investment Fund +1 | 11 to 50 | 2014 |
| 9 | Semble | Semble develops practice management and health record software for private healthcare providers. | Health care | London | Series C | $40.3M | 2026-06-04 | $67.2M | Octopus Ventures, Salica, Triple Point Ventures +2 | 101 to 250 | 2017 |
| 10 | Sava Technology | Sava Technology creates under-skin sensors that continuously monitor glucose, lactate, and ketones. | Biotech | London | Series B | $36.0M | 2026-10-09 | $62.8M | SOSV, Balderton Capital, Social Starts +1 | 101 to 250 | 2016 |
Table 2. Health care startups in the United Kingdom: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Innovate UK | Entrepreneurship program | Swindon, United Kingdom | 44 | 3% | 10 | Bioliberty, Directed Systems, Neuronostics |
| 2 | Techstars | Startup accelerator | New York, United States | 18 | 1% | ||
| 3 | Bethnal Green Ventures | Startup accelerator | London, United Kingdom | 16 | 1% | ||
| 4 | SFC Capital | Angel group | Northwich, United Kingdom | 15 | 1% | 2 | OSSTEC, Corryn Biotechnologies |
| 5 | Scottish Enterprise | Government investment office | Glasgow, United Kingdom | 13 | 1% | 3 | Bioliberty, Mironid, Mirna |
| 6 | Octopus Ventures | Venture capital firm | London, United Kingdom | 12 | 1% | 3 | Living Optics, Semble, KatKin |
| 7 | Ascension | Micro VC fund | London, United Kingdom | 11 | 1% | 3 | Qureight, Saltroad, Eolas Medical |
| 8 | Parkwalk Advisors | Venture capital firm | London, United Kingdom | 10 | 1% | 3 | OSSTEC, Adsilico, Brainomix |
| 9 | Future Planet Capital | Venture capital firm | London, United Kingdom | 9 | 1% | 2 | CellCentric, Nuclera |
| 10 | DigitalHealth.London Accelerator | Startup accelerator | London, United Kingdom | 9 | 1% | ||
| 11 | Oxford Science Enterprises | Venture capital firm | Oxford, United Kingdom | 8 | 1% | 1 | Living Optics |
| 12 | Plug and Play | Startup accelerator | Sunnyvale, United States | 8 | 1% | 2 | Dyad, Apoha |
| 13 | SOSV | Venture capital firm | Princeton, United States | 7 | 1% | 1 | Sava Technology |
| 14 | Y Combinator | Startup accelerator | Mountain View, United States | 7 | 1% | ||
| 15 | Eos | Venture capital firm | Saint Andrews, United Kingdom | 6 | 0% | 2 | Bioliberty, Neupulse |
Table 3. Health care startups in the United Kingdom: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 457 | 33% | $9.5B |
| Software | 432 | 31% | $2.4B |
| Artificial intelligence | 186 | 13% | $1.5B |
| Hardware | 90 | 6% | $364.4M |
| Commerce | 57 | 4% | $425.9M |
| Fintech | 40 | 3% | $47.7M |
| Education | 38 | 3% | $309.4M |
| Cybersecurity | 7 | 1% | $77.7M |
| Energy | 2 | 0% | $9.7M |
Table 4. Health care startups in the United Kingdom by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Health care startups in the United Kingdom by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Health care startups in the United Kingdom by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 6 | 4% | $261.3M |
| October 2026 | 21 | 12% | $566.2M |
| September 2026 | 24 | 14% | $302.0M |
| August 2026 | 2 | 1% | $70.9M |
| July 2026 | 14 | 8% | $231.5M |
| June 2026 | 26 | 15% | $383.1M |
| May 2026 | 12 | 7% | $413.8M |
| April 2026 | 11 | 6% | $94.9M |
| March 2026 | 12 | 7% | $63.6M |
| February 2026 | 17 | 10% | $54.3M |
| January 2026 | 10 | 6% | $58.8M |
| December 2025 | 10 | 6% | $118.7M |
| November 2025 | 5 | 3% | $141.1M |
Table 7. Health care startups in the United Kingdom: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 155 | 11% | $2.5B |
| 2025 | 148 | 11% | $1.6B |
| 2024 | 163 | 12% | $1.7B |
| 2023 | 156 | 11% | $839.7M |
| 2022 | 200 | 14% | $1.1B |
| 2021 | 126 | 9% | $1.5B |
Table 8. Health care startups in the United Kingdom by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 179 | 13% |
| 2020 to 2022 | 358 | 26% |
| 2015 to 2019 | 531 | 39% |
| 2010 to 2014 | 194 | 14% |
| Before 2010 | 111 | 8% |
Table 9. Health care startups in the United Kingdom by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 701 | 51% |
| 11 to 50 | 517 | 38% |
| 51 to 100 | 80 | 6% |
| 101 to 250 | 44 | 3% |
| 251 to 500 | 8 | 1% |
| 501 to 1,000 | 7 | 1% |
| 1,001 to 5,000 | 4 | 0% |
| 5,001 to 10,000 | 1 | 0% |
| 10,001 or more | 2 | 0% |
Table 10. Health care startups in the United Kingdom by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in the United Kingdom. On 16 November 2026 that is 1,388 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 1,388 rows: 327 have no round amount, 0 no city and 500 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in the United Kingdom are on the list?
- 1,388, in the file dated 16 November 2026. 170 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 1,388 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.